Laatste nieuws in bio
Dutch Startup Secures €1.67 Million to Make Hospital-Grade Heart Tests Available Anywhere
Netherlands, Saturday, 18 April 2026.
HeartEye’s breakthrough technology transforms complex 12-channel ECG recordings from a time-intensive hospital procedure requiring trained professionals into a simple one-minute test that can be performed by general practitioners, assistants, or nurses anywhere. The Dutch medtech company raised €1.675 million from ROM InWest and prominent tech investors to accelerate market introduction of their wireless ECG recorder. This innovation promises to detect heart conditions earlier while reducing unnecessary hospital referrals, potentially saving lives and cutting healthcare costs through improved accessibility to professional cardiac diagnostics.
Netherlands Cancer Rates Show Mixed Trends as Skin and Prostate Cases Rise Sharply
Amsterdam, Thursday, 16 April 2026.
While overall cancer risk in the Netherlands has decreased slightly since 2022, skin and prostate cancer cases are increasing dramatically due to aging demographics and past lifestyle choices. In 2025, approximately 134,756 people received cancer diagnoses, with lung cancer cases among women now equaling those in men for the first time. This shift reflects delayed smoking adoption by women during the 1960s flower power era, according to epidemiologists. The rise in skin cancer particularly affects those over 75, linked to decades of unprotected sun exposure and tanning bed use.
Scientists Create CRISPR Tool That Targets Only Cancer Cells
Wageningen, Wednesday, 15 April 2026.
Wageningen University researchers have developed ThermoCas9, a CRISPR variant that exploits methylation differences to selectively cut tumor DNA while leaving healthy cells untouched. This breakthrough addresses cancer’s ability to hide from detection by targeting subtle chemical markers.
Dutch Research Links Heavy Fertilizer Use to Dangerous Cadmium Buildup in Rice
Wageningen, Tuesday, 14 April 2026.
Wageningen University research reveals that intensive fertilizer application creates dangerous cadmium accumulation in soil and rice crops, potentially exceeding food safety limits. The study demonstrates that even beneficial soil management practices like manure use can pose long-term food safety risks. Researchers emphasize that simply adjusting farming practices or soil pH levels isn’t sufficient - comprehensive solutions require controlling industrial emissions alongside agricultural management. This finding challenges current circular agriculture approaches and highlights the complex relationship between soil health and food safety in modern farming systems.
Dutch AI Startup Secures €2.3 Million to Prevent Surgical Infections
Netherlands, Tuesday, 14 April 2026.
Netherlands-based Healthplus.ai has raised €2.3 million to expand its revolutionary PERISCOPE® system, which uses artificial intelligence to predict infection risks for individual patients after surgery. The technology can save hospitals up to €4 million annually by reducing postoperative complications and lowering staff workload pressures. Led by Elevating Capital and LUMO Labs, this funding will accelerate European rollout and launch US operations.
Dutch Tax Break Worth Nearly One Billion Euros Goes to US Pharma Giant That Closed Research Operations
Amsterdam, Monday, 13 April 2026.
American pharmaceutical company MSD received €922 million in Dutch innovation tax breaks in 2025, despite shutting down most research activities in the Netherlands. The company closed its main research facility in Oss in 2016, eliminating 1,000 jobs, and moved production to Ireland. MSD now benefits from the 9% tax rate through the ‘innovatiebox’ system simply by holding patents in a Dutch subsidiary, while contributing minimal innovation or employment to the country.